that would be the death sentence. Nobody would buy this share again without another board change. How many times has this already happened with ZYB? Nobody wants it, board change, they start buying again.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come